IMAX ($IMAX) posted quarterly earnings results on Thursday, October 23rd. The company reported earnings of $0.47 per share, beating estimates of $0.39 by $0.08. The company also reported revenue of $106,650,000, missing estimates of $107,258,100 by $-608,100.
You can see Quiver Quantitative's $IMAX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
IMAX Insider Trading Activity
IMAX insiders have traded $IMAX stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $IMAX stock by insiders over the last 6 months:
- RICHARD L GELFOND (Chief Executive Officer) sold 100,000 shares for an estimated $2,711,440
- ROBERT D LISTER (Chief Legal Officer Sr Exec VP) sold 20,000 shares for an estimated $656,000
- KENNETH IAN WEISSMAN (Deputy GC, Corp. Sec. & CCO) has made 0 purchases and 2 sales selling 15,072 shares for an estimated $386,560.
- GIOVANNI M. DOLCI (Chief Commercial Officer) sold 6,500 shares for an estimated $162,468
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
IMAX Hedge Fund Activity
We have seen 94 institutional investors add shares of IMAX stock to their portfolio, and 102 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ORBIS ALLAN GRAY LTD added 1,230,267 shares (+31.7%) to their portfolio in Q2 2025, for an estimated $34,398,265
- J. GOLDMAN & CO LP removed 648,332 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $18,127,362
- FMR LLC removed 609,311 shares (-12.2%) from their portfolio in Q2 2025, for an estimated $17,036,335
- WELLINGTON MANAGEMENT GROUP LLP added 535,788 shares (+inf%) to their portfolio in Q2 2025, for an estimated $14,980,632
- GOLDMAN SACHS GROUP INC added 488,086 shares (+154.0%) to their portfolio in Q2 2025, for an estimated $13,646,884
- BALYASNY ASSET MANAGEMENT L.P. added 449,497 shares (+inf%) to their portfolio in Q2 2025, for an estimated $12,567,936
- D. E. SHAW & CO., INC. added 401,950 shares (+271.3%) to their portfolio in Q2 2025, for an estimated $11,238,522
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
IMAX Analyst Ratings
Wall Street analysts have issued reports on $IMAX in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Roth Capital issued a "Buy" rating on 10/14/2025
- Barrington Research issued a "Outperform" rating on 09/23/2025
- Wedbush issued a "Outperform" rating on 09/22/2025
- Wells Fargo issued a "Overweight" rating on 07/25/2025
- Rosenblatt issued a "Buy" rating on 07/25/2025
- Benchmark issued a "Buy" rating on 07/25/2025
To track analyst ratings and price targets for IMAX, check out Quiver Quantitative's $IMAX forecast page.
IMAX Price Targets
Multiple analysts have issued price targets for $IMAX recently. We have seen 7 analysts offer price targets for $IMAX in the last 6 months, with a median target of $37.0.
Here are some recent targets:
- Eric Handler from Roth Capital set a target price of $40.0 on 10/14/2025
- David Karnovsky from JP Morgan set a target price of $31.0 on 10/09/2025
- Steve Frankel from Rosenblatt set a target price of $42.0 on 10/09/2025
- Patrick Sholl from Barrington Research set a target price of $37.0 on 09/23/2025
- Alicia Reese from Wedbush set a target price of $39.0 on 09/22/2025
- Mike Hickey from Benchmark set a target price of $32.0 on 07/25/2025
- Omar Mejias from Wells Fargo set a target price of $34.0 on 07/25/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
